Citruslabs
Las Vegas, Nevada, 89101, United States
NCT Number: NCT07781332
This single-group trial evaluates the efficacy of FlavCity's Sleep Gummy supplement on sleep health in adults aged 20-50 who self-report issues with sleep. Forty participants will take one sleep gummy nightly (30 minutes before bed) for 7 days while wearing a Fitbit Inspire 3 sleep tracker to monitor objective sleep metrics.
Participants will complete study-specific questionnaires and report sleep tracker data at Baseline, Day 1 (the day after first use), and Day 7. The study is conducted entirely virtually. Primary outcomes focus on sleep quality and quantity (including time to fall asleep, deep sleep, REM sleep, and grogginess upon waking), assessed via the validated Sleep Quality Scale (SQS) and sleep tracking biomarkers. Secondary outcomes assess participant perceptions of the product.
Looking for future studies?
Notify Me20 year–50 year
All sexes
Interventional
Not applicable
Las Vegas, Nevada, 89101, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All enrolled participants receive FlavCity Sleep Gummy, one gummy taken orally 30 minutes before bedtime (at least one hour after the evening meal) daily for 7 consecutive days.
Time frame: Baseline, Day 1, and Day 7
Change from baseline in sleep quality score as assessed using the validated Sleep Quality Scale (SQS) self-reported questionnaire.
Time frame: Baseline, Day 1, and Day 7
Change from baseline in sleep score measured using the Fitbit Inspire 3 sleep tracker.
Time frame: Baseline, Day 1, and Day 7
Change from baseline in sleep onset latency, measured using the Fitbit Inspire 3 sleep tracker and reported in minutes.
Time frame: Baseline, Day 1, and Day 7
Assessed via Fitbit Inspire 3 sleep tracker data
Time frame: Baseline, Day 1, and Day 7
Assessed via Fitbit Inspire 3 sleep tracker data
Time frame: Baseline, Day 1, and Day 7
Assessed via Fitbit Inspire 3 sleep tracker data and self-reported questionnaire using the Sleep Quality Scale (SQS)
Time frame: Baseline, Day 1, and Day 7
Assessed via Fitbit Inspire 3 sleep tracker data
Time frame: Baseline, Day 1, and Day 7
Assessed via Fitbit Inspire 3 sleep tracker data
Time frame: Day 1 and Day 7
Assessed via self-reported product perception questionnaire
Time frame: Day 1 and Day 7
Assessed via self-reported product perception questionnaire
Time frame: Day 1 and Day 7
Assessed via self-reported product perception questionnaire
Time frame: Day 1 and Day 7
Assessed via self-reported product perception questionnaire
DTBE, LLC dba FlavCity
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05567107
Bypass Complication, Dyssomnias
Erzurum, palandöken, Turkey (Türkiye)
View Trial DetailsNCT07386691
Dyssomnias, Fatigue
Baghdad, Iraq
View Trial DetailsNCT07769164
Dyssomnias, Mental Disorders
Sarasota, Florida, United States
View Trial DetailsNCT07767318
Complementary Alternative Medicine, Dyssomnias
Malatya, Turkey (Türkiye)
View Trial Details